
Browsing restrictions can be lifted for a fee.
3.04%
Alignment healthcare, inc.
0.05%
Avg of Sector
-0.31%
S&P500

Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2026Q1 | ||||
| 2026Q2 | ||||
| 2026Q3 | ||||
| 2026Q4 | ||||
| 2027Q1 |
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2025Q4 | |||||||
| 2025Q3 | |||||||
| 2025Q2 | |||||||
| 2025Q1 |
The most recent financial report for Alignment healthcare, inc. (ALHC) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ALHC's short-term business performance and financial health. For the latest updates on ALHC's earnings releases, visit this page regularly.
According to the latest financial report, Alignment healthcare, inc. (ALHC) reported an Operating Profit of -10.28M with an Operating Margin of -1.02% this period, representing a growth of 54.38% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, Alignment healthcare, inc. (ALHC) announced revenue of 1.01B, with a Year-Over-Year growth rate of 44.43%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, Alignment healthcare, inc. (ALHC) held Total Cash and Cash Equivalents of 575.82M, accounting for 0.54 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, Alignment healthcare, inc. (ALHC) did not achieve the “three margins increasing” benchmark, with a gross margin of 12.2%%, operating margin of -1.02%%, and net margin of -1.1%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ALHC's profit trajectory and future growth potential.
According to the past four quarterly reports, Alignment healthcare, inc. (ALHC)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.05. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
Alignment healthcare, inc. (ALHC)'s Free Cash Flow (FCF) for the period is -55.4M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 207.89% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
The latest valuation data shows Alignment healthcare, inc. (ALHC) has a Price-To-Earnings (PE) ratio of -5,423.45 and a Price/Earnings-To-Growth (PEG) ratio of 0.23. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.